Charles River Laboratories Announces First-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Charles River Laboratories (CRL) Tops Q1 EPS by 2c, Reaffirms 2019 Guidance
May 7, 2019 7:08 AM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $604.6 million versus the consensus estimate of $595.66 million.
The Company is reaffirming its revenue growth and non-GAAP earnings per share guidance for 2019... More